David E. Goldgar
Professor
Cancer Control & Population Sciences
Huntsman Cancer Institute
United States of America
Biography
David Goldgar, PhD, is a research professor in the Department of Dermatology at the University of Utah and member of the Cancer Control and Population Sciences (CCPS) Program at Huntsman Cancer Institute.Goldgar's research involves the genetic study of breast cancer and melanoma. He studies methods to clinically classify the BRCA1 and BRCA2 genes, the most well-known genes for breast cancer.Before leaving the University of Utah to assume the position of chief of the Genetic Epidemiology Unit at the International Association of Cancer Research in Lyon, France, Goldgar was a member of the team that led to the localization, cloning, or characterization of the cancer predisposing BRCA1, BRCA2, and CDKN2A (p16) mutations. Goldgar joined the CCPS Program in 2008 upon his return to the University of Utah.Goldgar earned a bachelor's degree and PhD from the University of Colorado, Boulder.
Research Interest
Cancer Control & Population Sciences
Publications
-
Stratton MR, Ford D, Neuhausen S, Seal S, Wooster R, Friedman LS, King M-C, Egilsson V, Devilee P, McMarus R, Daly PA, Smith E, Ponder BAJ, Peto J, Cannon-Albright L, Easton D, Goldgar D (1994). Familial male breast cancer is not linked to BRCA1 locus on chromosome 17q. Nature Genetics, 7, 103-106.
-
Chenevix-Trench G, Milne RL, Antoniou AC, Couch FJ, Easton DF, Goldgar DE (2007). An international initiative to identify genetic modifiers of cancer risk in BRCA1 and BRCA2 mutation carriers: the Consortium of Investigators of Modifiers of BRCA1 and BRCA2 (CIMBA). Breast Cancer Res, 9(2), 104.
-
Vogl FD, Badzioch MD, Steele L, Neuhausen SL, Goldgar DE (2007). Risks of cancer due to a single BRCA1 mutation in an extended Utah kindred. Fam Cancer, 6(1), 63-71.
